5047UH0368065047 552937f

Cert. No.
MC-2737
COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

ACCESSION NO : 5047UH036806 PERM ID : PRIYF1008735047A
PATIENT NAME : MRS. PRIYA BHOJWANI AGE / SEX : 48 Years / Female
REFFERED BY : : SELF CENTRE : CS00007750
CLIENTPATIENT ID : HARMONY CLINIC (BANDRA W)
HAEMATOLOGY
TEST RESULT BIOLOGICAL UNIT
REFERENCE RANGE
COMPREHENSIVE BODY PROFILE
INDICES
HAEMOGLOBIN 12.9 12.0 - 15.0 gm%
METHOD : (SLS)
R.B.C. COUNT 5.06 High 3.80 - 4.80 mil/µL

METHOD : (ELECTRICAL IMPEDENCE)
P.C.V. 41.6 36.0 - 46.0 %

METHOD : (PULSE HT.DETECTION)
M.C.V. 82.2 Low 83.0 - 101.0 fl

METHOD : (CALCULATED)
M.C.H. 25.5 Low 27.0 - 32.0 pg

M.C.H.C. 31.0 Low 31.5 - 34.5 g/dl

R.D.W.-C.V. 17.0 High 11.6 - 14.0 %
DIFFERENTIAL AND W.B.C. COUNTS

W.B.C. COUNT 6210 4000 - 10000 /Cmm
METHOD : FLOWCYTOMETRY
NEUTROPHILS 61 40 - 80 %
LYMPHOCYTES 30 20 - 40 %
EOSINOPHILS 1 1-6 %
MONOCYTES 8 2 - 10 %
BASOPHILS 00 <1-2 %
ABSOLUTE NEUTROPHILS COUNT 3788 2000 - 7000 /c.mm
ABSOLUTE LYMPHOCYTES COUNT 1863 1000 - 3000 /c.mm
ABSOLUTE EOSINOPHILS COUNT 62 20 - 500 /c.mm
ABSOLUTE MONOCYTES COUNT 497 200 - 1000 /c.mm
ABSOLUTE BASOPHILS COUNT 0 20 - 100 /c.mm
NEUTROPHIL TO LYMPHOCYTE RATIO 2.0 0.78 - 3.53 RATIO
PLATELETS
Page 1 Of 16
DR. ALVIN ALVA (MD)

CONSULTANT PATHOLOGIST
Report Printed On:14/08/2021 02:45 PM
Scan to View Details

Cert. No. MC-2737

HAEMATOLOGY
REFERENCE RANGE
PLATELET COUNT 362000 150000 - 410000 /cu.mm.

METHOD : ELECTRICAL IMPEDENCE
PLATELET ON SMEAR Adequate On Smear
E.S.R. (WHOLE BLOOD)

E.S.R. 11 0 - 12 mm/hr
In Pregnancy :-
First Half : 00 - 48
(62 If anaemic)
Second Half : 00 - 70
(95 If Anaemic)
METHOD : AUTOMATED (PHOTOMETRICAL CAPILLARY STOPPED FLOW KINETIC ANALYSIS).
INTERPRETATION
E.S.R. (WHOLE BLOOD)-Erythrocyte sedimentation rate (ESR) is a test that indirectly measures the degree of inflammation
present in the body.
Method of test: The test actually measures the rate of fall (sedimentation) of erythrocytes (red blood cells) in a sample of blood
that has been placed into a tall, thin, vertical tube. Results are reported as the millimetres of clear fluid (plasma) that are present
at the top portion of the tube after one hour.The result of an ESR is reported as the millimetres of clear fluid (plasma) that are
present at the top portion of the tube after one hour (mm/hr).
Interpretation:
The ESR is not diagnostic it is a non-specific test that may be elevated in a number of these different conditions. It provides
general information about the presence or absence of an inflammatory condition. CRP is superior to ESR because it is more
sensitive and reflects a more rapid change
Increased in:
• Infections
• Vasculities
• Inflammatory arthritis
• Renal disease
• Anemia
• Malignancies and plasma cell dyscrasias
• Acute allergy
• Tissue injury
• Pregnancy(Not in the 1st TMP)
• Estrogen medication
• Aging
• Finding a very accelerated ESR(>100 mm/hour) in patients will ill-defined symptoms directs the physician to search for
a systemic disease(Paraproteinemias, Disseminated malignancies, connective tissue disease, severe infections such as bacterial
endocarditis)
Decreased in:
• Polycythermia vera
Page 2 Of 16
DR. ALVIN ALVA (MD)


Cert. No. MC-2737

HAEMATOLOGY
REFERENCE RANGE
• Sickle cell anemia
Limitations
False elevated ESR:
• Increased fibrinogen
• Drugs(Vitamin A, Dextran etc)
• Hypercholesterolemia
False Decreased ESR:
• Abnormally shaped RBCs(Sickle Cells,spherocytes)
• Microcytosis
• Low fibrinogen
• Very high WBC counts
• Drugs(Quinine, salicylates)
Page 3 Of 16
DR. ALVIN ALVA (MD)


Cert. No. MC-2737

BIO CHEMISTRY
REFERENCE RANGE
BUN (UREASE ENZYMATIC KINETIC), SERUM

BLOOD UREA NITROGEN (BUN) 8.3 8 - 21 mg/dL
METHOD : (UREASE ENZYMATIC KINETIC)
CREATININE
SERUM CREATININE 0.7 0.4 - 1.2 mg/dL
Please note change in

reference range
METHOD : JAFFE-KINETIC
S.URIC ACID (URICASE ENZYMATIC)

SERUM URIC ACID 4.5 3.0 - 5.9 mg/dL
METHOD : URICASE ENZYMATIC
CALCIUM
SERUM CALCIUM 9.0 8.1 - 10.4 mg/dL
METHOD : NM BAPTA
SERUM PHOSPHORUS
SERUM PHOSPHORUS 3.8 2.8 - 4.5 mg/dL
METHOD : AMMONIUM PHOSPHOMOLYBDATE
S. SODIUM (ION SELECTIVE ELECTRODE)

SERUM SODIUM 137.0 135 - 145 mEq/L
METHOD : ION SELECTIVE ELECTRODE
S.POTASSIUM (ION SELECTIVE ELECTRODE)

SERUM POTASSIUM 4.4 3.9 - 5.3 mEq/L
S.CHLORIDES (ION SELECTIVE ELECTRODE)

SERUM CHLORIDE 100.0 96 - 109 mEq/L
CO2 COMB. POWER (PEP), SERUM/PLASMA
Page 4 Of 16
Dr. Geetha Chandrashekhar,

MD
Consultant Pathologist

Cert. No. MC-2737

BIO CHEMISTRY
REFERENCE RANGE
CO2 COMB. POWER (PEP) 23.3 17 - 31 mEq/L
*ESTIMATED GFR [EGFR]

AGE 48
CREATININE 0.7 0.4 - 1.2 mg/dL
reference range
ESTIMATED GFR [EGFR] FEMALE 102.8 ml/min/1.73 m²
METHOD : CKD-EPI EQUATION
Page 5 Of 16

MD

Cert. No. MC-2737


REFERENCE RANGE
ESTIMATION OF BLOOD SUGAR F AND PP

PLASMA FASTING , GLUCOSE 87.0 Normal < 100 mg/dL
Impaired fasting
glucose:100 to 125
Diabetes mellitus : >=
126
(on more than one
occassion)
(American diabetes
association
guidelines 2017)
PLASMA GLUCOSE (2 HRS.) 98.0 Normal < 140 mg/dL
Impaired glucose
tolerance:140 to 199
Diabetes mellitus : >=
200
(on more than one
occassion)
(American diabetes
association
guidelines 2017)
Page 6 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737

BIOCHEMISTRY-HB
REFERENCE RANGE
GLYCOSYLATED HEMOGLOBIN (HBA1C), EDTA WHOLE BLOOD

GLYCOSYLATED HAEMOGLOBIN (HBA1C) 5.6 >8 % Action %
suggested
>6.5 % Diabetic level
5.7 - 6.4 % Pre
Diabetic level
MEAN PLASMA GLUCOSE (MPG) ESTIMATE 114.02 mg/dL
METHOD : BY HPLC
Page 7 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737


REFERENCE RANGE
LIVER PROFILE
SERUM ASPARTATE 18 15 - 45 U/L
AMINOTRANSAMINASE (SGOT)
METHOD : (IFCC)
SERUM ALANINE AMINOTRANSFERASE 15 10 - 40 U/L

(SGPT)
METHOD : (IFCC)
SERUM TOTAL BILIRUBIN 0.3 0 - 1.0 mg/dL

METHOD : (DIAZO)
SERUM DIRECT BILIRUBIN 0.1 0 - 0.60 mg/dL

METHOD : (DIAZO)
SERUM INDIRECT BILIRUBIN 0.20 0 - 0.40 mg/dL

SERUM TOTAL PROTEIN 7.3 6.3 - 8.6 g/dL

METHOD : (BIURET)
SERUM ALBUMIN 4.1 3.7 - 5.6 g/dL

METHOD : (BROMOCRESOL GREEN)
SERUM GLOBULIN 3.2 1.5 - 3.5 g/dL

ALBUMIN/GLOBULIN RATIO 1.3 0.9 - 2.0 Ratio

SERUM ALKALINE PHOSPHATASE 71.0 40 - 129 U/L

METHOD : IFCC
SERUM GGT 16.0 8 - 78 U/L

METHOD : (SZAZ METHOD)
Page 8 Of 16

MD

Cert. No. MC-2737

BIOCHEM-LI
REFERENCE RANGE
LIPID PROFILE
SERUM CHOLESTEROL 186.6 DESIRABLE : < 200 mg/dL
BORDERLINE HIGH:
200 - 239
HIGH : > 240
METHOD : (CHOD-PAP)
SERUM TRIGLYCERIDE 108.6 <160 mg/dL

METHOD : (GPO - PAP)
SERUM HDL CHOLESTEROL 50.1 LOW : <40 mg/dL

HIGH: >60
METHOD : (HOMOGENEOUS ENZYMATIC)
SERUM LDL CHOLESTEROL 114.8 OPTIMAL <100 mg/dL

NEAR OR ABOVE
NORMAL 100- 129
BORDERLINE HIGH
130-159
HIGH 160 - 189
VERY HIGH >190
SERUM CHOLESTEROL / HDL 3.7 Less than 5

NON HDL CHOLESTEROL 136.5 Optimal : <130 mg/dL

Desirable : 130 - 159
Borderline high : 159-
189
High : 189 - 220
Very High : >=220
SERUM VLDL CHOLESTEROL 21.7 10 - 40 mg/dl

LDL/HDL RATIO 2.3 Low 2.5 - 3.5

Page 9 Of 16

MD

Cert. No. MC-2737

IMMUNOASSAY
REFERENCE RANGE
25-HYDROXY VITAMIN D
25 - HYDROXY VITAMIN D (SERUM) 30.8 Deficiency(seriously ng/ml
deficient):
<10
Insufficiency
(deficient):
10-30
Sufficiency(adequately
supplied) :
30 - 100
Toxicity > 100
METHOD : CLIA
Page 10 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737

ALLERGY
REFERENCE RANGE
PHADIATOP, SERUM
PHADIATOP 4.47 High Negative < 0.35 kUA/L
Positive > =0.35
METHOD : IMMUNOCAP
Page 11 Of 16
Dr. Ajay Phadke M.D.


Cert. No. MC-2737

CLINICAL PATH
REFERENCE RANGE
URINE PHYSICAL EXAMINATION

COLOUR LYELLOW PALE YELLOW
APPEARANCE SLIGHTLY HAZY CLEAR
DEPOSIT ABSENT ABSENT
REACTION PH 7.0 4.6 - 8.0
SPECIFIC GRAVITY 1.006 1.003 - 1.035
CHEMICAL EXAMINATION
URINE PROTEIN ABSENT ABSENT
METHOD : BIURET
URINE KETONES ABSENT ABSENT

METHOD : NITROPRUSSIDE
URINE GLUCOSE ABSENT ABSENT Gm.%

METHOD : GOD,POD
BILE SALT ABSENT ABSENT

METHOD : SULPHUR POWDER (MANUAL METHOD)
BILE PIGMENT ABSENT ABSENT

METHOD : FOUCHETS METHOD (MANUAL METHOD)
BLOOD ABSENT ABSENT

METHOD : PEROXIDASE
UROBILINOGEN NORMAL NORMAL

METHOD : AZO COUPLING
NITRITES ABSENT ABSENT

METHOD : GRIESS
MICROSCOPIC EXAMINATION
RED BLOOD CELLS ABSENT 0-2 /hpf
PUS CELLS 12.4 High 0-5 /hpf
EPITHELIAL CELLS 6.0 High 0-5 /hpf
CASTS ABSENT ABSENT
CRYSTALS ABSENT ABSENT
AMORPHOUS MATERIAL ABSENT ABSENT
Page 12 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737

CLINICAL PATH
REFERENCE RANGE
BACTERIA FEW ABSENT

TRICHOMONAS VAGINALIS ABSENT ABSENT
SPERMATOZOA ABSENT ABSENT
NOTE
Page 13 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737

IMMUNOASSY-THY
REFERENCE RANGE
THYROID FUNCTION TESTS

TOTAL T3 (TRIIODOTHYRONINE), SERUM 80.30 Euthyroid : 58 - 159 ng/dL
Hypothyroid : < 58
Hyperthyroid : > 159

reference range.
METHOD : CMIA
TOTAL T4 (THYROXINE), SERUM 6.80 Euthyroid : 4.87 - µg/dL

11.72
Hypothyroid : < 4.87
Hyperthyroid : >
11.72

reference range.
METHOD : CMIA
TSH (ULTRA SENSITIVE), SERUM 2.54 Euthyroid : 0.35 - 4.94 µIU/ML

Hypothyroid : > 4.94
Hyperthyroid : < 0.35

reference range.
METHOD : CMIA
Page 14 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737

IMMUNOASSY-THY
REFERENCE RANGE
Page 15 Of 16
DR. SONAL PRIYA


Cert. No. MC-2737

IMMUNOASSY-VIT
REFERENCE RANGE
VITAMIN B 12 (CYANOCOBALAMINE)
VITAMIN B12 (CYANOCOBALAMINE), 334.00 187 - 883 pg/ml
SERUM
METHOD : CLIA
Page 16 Of 16
DR. SONAL PRIYA


5047UH0368065047 552937f

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

5047UH0368065047 552937f

Uploaded by

Copyright:

Available Formats

Cert. No.

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

COMPREHENSIVE BODY PROFILE

R.B.C. COUNT 5.06 High 3.80 - 4.80 mil/µL

P.C.V. 41.6 36.0 - 46.0 %

M.C.V. 82.2 Low 83.0 - 101.0 fl

M.C.H. 25.5 Low 27.0 - 32.0 pg

M.C.H.C. 31.0 Low 31.5 - 34.5 g/dl

R.D.W.-C.V. 17.0 High 11.6 - 14.0 %

DIFFERENTIAL AND W.B.C. COUNTS

DR. ALVIN ALVA (MD)

Report Printed On:14/08/2021 02:45 PM

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

PLATELET COUNT 362000 150000 - 410000 /cu.mm.

PLATELET ON SMEAR Adequate On Smear

E.S.R. (WHOLE BLOOD)

DR. ALVIN ALVA (MD)

Report Printed On:14/08/2021 02:45 PM

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

• Sickle cell anemia

DR. ALVIN ALVA (MD)

Report Printed On:14/08/2021 02:45 PM

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

COMPREHENSIVE BODY PROFILE

BUN (UREASE ENZYMATIC KINETIC), SERUM

Please note change in

S.URIC ACID (URICASE ENZYMATIC)

S. SODIUM (ION SELECTIVE ELECTRODE)

S.POTASSIUM (ION SELECTIVE ELECTRODE)

S.CHLORIDES (ION SELECTIVE ELECTRODE)

CO2 COMB. POWER (PEP), SERUM/PLASMA

Dr. Geetha Chandrashekhar,

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

CO2 COMB. POWER (PEP) 23.3 17 - 31 mEq/L

*ESTIMATED GFR [EGFR]

Dr. Geetha Chandrashekhar,

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

TEST RESULT BIOLOGICAL UNIT

COMPREHENSIVE BODY PROFILE

ESTIMATION OF BLOOD SUGAR F AND PP

DR. SONAL PRIYA

Report Printed On:14/08/2021 02:45 PM

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

COMPREHENSIVE BODY PROFILE

GLYCOSYLATED HEMOGLOBIN (HBA1C), EDTA WHOLE BLOOD

DR. SONAL PRIYA

Report Printed On:14/08/2021 02:45 PM

Scan to View Details

COLLECTION DATE : 10/08/2021 02:37 PM REPORTING DATE : 10/08/2021 07:17 PM

TEST RESULT BIOLOGICAL UNIT

COMPREHENSIVE BODY PROFILE

SERUM ALANINE AMINOTRANSFERASE 15 10 - 40 U/L

SERUM TOTAL BILIRUBIN 0.3 0 - 1.0 mg/dL

SERUM DIRECT BILIRUBIN 0.1 0 - 0.60 mg/dL

SERUM INDIRECT BILIRUBIN 0.20 0 - 0.40 mg/dL

SERUM TOTAL PROTEIN 7.3 6.3 - 8.6 g/dL